Milnacipran

This classification denotes an antidepressant agent and adrenergic agent with the molecular formula C15H22N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G56VK1HF36, chemically known as cyclopropanecarboxamide, 2-(aminomethyl)-n,n-diethyl-1-phenyl-, cis-(+-)- but generally known as milnacipran, which bears US NIH Compound Identifier 65833. European Medicines Agency schedules Milnacipran in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08965MIG. The term MILNACIPRAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). World Health Organization schedules milnacipran in its Anatomical Therapeutic Chemical (ATC) Classification. MILNACIPRAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule milnacipran under HS 29242995 and SITC 51479. As of Q4 2014, MILNACIPRAN remains the US FDA Preferred Term for this commodity. Milnacipran bears US NLM identifiers UMLS ID C1533126 and NCI Concept Code C78021. SMILES: O=C(N(CC)CC)C1(C(C1)CN)c1ccccc1.